SCHEMBL17628208

SCHEMBL17628208

CCN(C(=O)OC(C)(C)C)C1CCN(c2nc(Cl)nc3c2CCCC3)C1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CFTR P13569 2/20 0.42
HRH4 Q9H3N8 3/20 0.36
SPR P35270 1/20 0.36
CCR5 P51681 1/20 0.35
PDE10A Q9Y233 1/20 0.34
HSD11B1 P28845 2/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
NR4A1 P22736 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CTSS P25774 1/20 0.31
GBA1 P04062 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPK1 P28482 1/20 0.31
JAK3 P52333 1/20 0.31
BTK Q06187 1/20 0.31
AAK1 Q2M2I8 1/20 0.31
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17628211 1.00 CFTR (0.42) CFTRHRH4SPRCCR5PDE10A
SCHEMBL17628270 0.87 SPR (0.46) CFTRHRH4SPRPDE10AHSD11B1
SCHEMBL17628272 0.87 SPR (0.46) CFTRHRH4SPRPDE10AHSD11B1
SCHEMBL17667274 0.83 SPR (0.43) HRH4SPRPDE10AHSD11B1GBA1
SCHEMBL17667288 0.81 SPR (0.45) HRH4SPRPDE10AHSD11B1LMNA
SCHEMBL17628307 0.79 HRH4 (0.38) CFTRHRH4LMNATSHRNR4A1
SCHEMBL17667275 0.78 HRH4 (0.35) CFTRHRH4CTSSGBA1JAK3
SCHEMBL17628388 0.77 JAK3 (0.48) HRH4PDE10AJAK3BTK
SCHEMBL17628389 0.77 JAK3 (0.48) HRH4PDE10AJAK3BTK
SCHEMBL17667289 0.76 HRH4 (0.35) CFTRHRH4LMNATSHRNR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152241-A9 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR YUHAN CORPORATION (KR) 2017-06-01 US disclosed
EP-3006439-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR Yuhan Corporation (KR) 2016-04-13 EP disclosed
US-20160090374-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR YUHAN CORP (KR) 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152241-A9 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR GPR119, GIPR, P2RY4 CFTR 329/4885HRH4 4/4885SPR 1238/4885
US-20160090374-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR GPR119, GIPR, P2RY4 CFTR 329/4885HRH4 4/4885SPR 1238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.